甲状腺微小乳头状癌相关预后指标的研究  

Study on prognosis of papillary thyroid microcarcinoma

作　　者：汪义淇 代文杰[1] 

机构地区：[1]哈尔滨医科大学附属第一医院甲状腺外科,150050

出　　处：《临床外科杂志》2018年第2期155-156,共2页Journal of Clinical Surgery

摘　　要：随着公众对甲状腺疾病认识的提高以及超声技术的发展,关于甲状腺微小乳头状癌的研究受到关注。大多数甲状腺微小乳头状癌病人预后良好,但也存在术后复发及淋巴结转移的问题。我们对甲状腺微小乳头状癌相关预后指标的现状和进展进行综述,主要内容包括病人临床信息、免疫学组织标志物及BRAF基因等。With the public awareness of thyroid disease and the development of ultrasound technology,more attention has been paid to the study of the papillary thyroid microcarcinomas（PTMCs）.Most thyroid small papillary carcinomas have good prognosis,but postoperative recurrence and lymph node metastasis also occurs.Here,the current status and progress of prognostic factors for papillary thyroid microcarcinoma are reviewed.The primary coverage includes clinical information,immunological markers and BRAF genes.

关 键 词：甲状腺微小乳头状癌 BRAF基因 免疫组织学标志物 

分 类 号：R736.1[医药卫生—肿瘤]